http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016528213-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
filingDate 2014-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2016528213-A
titleOfInvention Antiviral compounds, pharmaceutical compositions and methods of use thereof
abstract Disclosed are compounds, pharmaceutical compositions and methods for the treatment of viral infections, including RNA viral infections, and methods of modulating the RIG-I pathway in subjects and / or cells.
priorityDate 2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419711555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426320757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466588711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467856055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466298826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9813852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466381920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12241082

Total number of triples: 41.